scholarly article | Q13442814 |
P2093 | author name string | Yu-Feng Wang | |
Sha-Sha Li | |||
Huan Ma | |||
Hui-Lai Miao | |||
Jia-Yuan Wu | |||
P2860 | cites work | Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 |
Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center | Q33597332 | ||
Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes | Q33987127 | ||
Decision curve analysis: a novel method for evaluating prediction models | Q34581068 | ||
The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm | Q35920101 | ||
How to build and interpret a nomogram for cancer prognosis | Q37103518 | ||
Marital status independently predicts pancreatic cancer survival in patients treated with surgical resection: an analysis of the SEER database | Q37269479 | ||
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Q38017783 | ||
European experts consensus statement on cystic tumours of the pancreas | Q38082207 | ||
Patterns of Recurrence After Resection of IPMN: Who, When, and How? | Q38385287 | ||
Prognostic models and nomograms for predicting survival of patients with maxillary sinus carcinomas | Q38763662 | ||
Pancreatic Cyst Disease: A Review | Q38823844 | ||
Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium | Q39025112 | ||
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas | Q39452846 | ||
Selecting optimal surgical procedures for intraductal papillary mucinous neoplasm (IPMN): An analysis based on the Surveillance, Epidemiology, and End Result registry database. | Q39583043 | ||
Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies | Q41120771 | ||
Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas | Q41130771 | ||
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers | Q41814979 | ||
Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma | Q43452944 | ||
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis | Q43613552 | ||
Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. | Q45980129 | ||
The Impact of Surgeons on the Likelihood of Mastectomy in Breast Cancer | Q49713019 | ||
Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection. | Q50050497 | ||
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature | Q50096468 | ||
My Treatment Approach: Pancreatic Cysts | Q50176510 | ||
American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. | Q50575965 | ||
Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines? | Q55292571 | ||
Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential. | Q55410325 | ||
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data | Q58119482 | ||
Nomograms for estimating survival in patients with liver-only colorectal metastases: A retrospective study | Q58567675 | ||
Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: an Analysis of the Surveillance, Epidemiology, and End Results Registry | Q64684593 | ||
Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas | Q80269666 | ||
Prevalence of Extrapancreatic Malignancies Among Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas | Q88715063 | ||
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance | Q88872713 | ||
Application of net reclassification index to non-nested and point-based risk prediction models: a review | Q89338036 | ||
Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours | Q90783686 | ||
Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN) | Q91875183 | ||
Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis | Q92887540 | ||
P433 | issue | 5 | |
P304 | page(s) | 535-549 | |
P577 | publication date | 2020-02-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study | |
P478 | volume | 26 |
Search more.